Search results
Feb 15, 2024 · 8 FDA-Approved Drugs for Weight Management. By Phuoc Anh (Anne) Nguyen, PharmD, MS, BCPS. Updated on February 15, 2024. Medically reviewed by Lindsay Cook, PharmD. Print. Table of Contents. View All. Xenical (Orlistat) Alli (Orlistat) Contrave (Bupropion-Naltrexone) Saxenda (Liraglutide) Qsymia (Phentermine-Topiramate)
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
Nov 8, 2023 · FDA Approves New Medication for Chronic Weight Management. For Immediate Release: November 08, 2023. Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide)...
The table below lists prescription drugs approved by the FDA for weight loss. The FDA has approved five of these drugs—orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), and semaglutide (Wegovy)—for long-term use.
News about Ozempic, weight loss drugs, Hims & Hers
News about Weight-Loss Drugs, Ozempic, GLP-1
Also in the news
Nov 8, 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy. Eli Lilly & Co.,...
Nov 9, 2023 · On Nov. 8, the U.S. Food and Drug Administration (FDA) approved tirzepatide (which will be sold under the brand name Zepbound), to treat overweight and obesity. Made by Eli Lilly and Co., the...
Nov 8, 2023 · CNN. The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely...
